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SUMMARY 
	  
Pre-mRNA splicing relies on the poorly 
understood dynamic interplay between >150 
protein compo- nents of the spliceosome. The 
steps at which splicing can be regulated remain 
largely unknown. We sys- tematically analyzed 
the effect of knocking down the components of 
the splicing machinery on alterna- tive splicing 
events relevant for cell proliferation and apoptosis 
and used this information to reconstruct a 
network of functional interactions. The network 
accurately captures known physical and 
functional associations and identifies new ones, 
revealing remarkable regulatory potential of core 
spliceosomal components, related to the order 
and duration of their recruitment during 
spliceosome assembly. In contrast with standard 
models of regulation at early steps of splice site 
recognition, factors involved in catalytic 
activation of the spliceosome display regu- latory 
properties. The network also sheds light on the 
antagonism between hnRNP C and U2AF, and on tar- 
gets of antitumor drugs, and can be widely used 
to identify mechanisms of splicing regulation. 
	  
	  
INTRODUCTION 
	  
Pre-mRNA splicing is carried out by the spliceosome, one of the 
most complex molecular machineries of the cell, composed of 
five small nuclear ribonucleoprotein particles (U1, U2, U4/5/6 
snRNP) and about 150 additional polypeptides (reviewed by 
Wahl et al., 2009). Detailed biochemical studies using a small 
number of model introns have delineated a sequential pathway 
for the assembly of spliceosomal subcomplexes. For example, 
U1 snRNP recognizes the 5’ splice site, and U2AF—a hetero- 
dimer of 35 and 65 kDa subunits—recognizes sequences at 
the 3’ end of introns. U2AF binding helps to recruit U2 snRNP 
to the upstream branchpoint sequence, forming complex A. U2 
snRNP binding involves interactions of pre-mRNA sequences 
with U2 snRNA as well as with U2 proteins (e.g., SF3B1). Subse- 
quent binding of preassembled U4/5/6 tri-snRNP forms complex 
B, which after a series of conformational changes forms com- 
plexes Bact and C, concomitant with the activation of the two 
catalytic steps that generate splicing intermediates and prod- 
ucts. Transition between spliceosomal subcomplexes involves 
profound dynamic changes in protein composition as well as 
extensive rearrangements of base-pairing interactions between 
snRNAs and between snRNAs and splice site sequences (Wahl 
et al., 2009). RNA structures contributed by base-pairing interac- 
tions between U2 and U6 snRNAs serve to coordinate metal ions 
critical for splicing catalysis (Fica et al., 2013), implying that the 
spliceosome is an RNA enzyme whose catalytic center is only 
established upon assembly of its individual components. 
Differential selection of alternative splice sites in a pre-mRNA 
(alternative splicing, AS) is a prevalent mode of gene regulation in 
multicellular organisms, often subject to developmental regula- 
tion (Nilsen and Graveley, 2010) and frequently altered in disease 
(Cooper et al., 2009; Bonnal et al., 2012). Substantial efforts 
made to dissect mechanisms of AS regulation on a relatively 
small number of pre-mRNAs have provided a consensus picture 
in which protein factors recognizing cognate auxiliary sequences 
in the pre-mRNA promote or inhibit early events in spliceosome 
assembly (Fu and Ares, 2014). These regulatory factors include 
members of the hnRNP and SR protein families, which often 
display cooperative or antagonistic functions depending on the 
position of their binding sites relative to the regulated splice sites. 
Despite important progress (Barash et al., 2010; Zhang et al., 
2010), the combinatorial nature of these contributions compli- 
cates the formulation of integrative models for AS regulation. 
To systematically capture the contribution of splicing regulato- 
ry factors, including components of the core spliceosome (Clark 
et al., 2002; Park et al., 2004; Pleiss et al., 2007; Saltzman et al., 
2011) to AS regulation, we set up a high-throughput screen to 
evaluate the effects of knocking down each individual splicing 
component or regulator on 36 functionally important AS events 
(ASEs) and developed a framework for data analysis and 
network modeling. Network-based approaches can provide 
rich representations for real-world systems that capture their or- 
ganization more adequately than more traditional approaches or 
mere cataloguing of pairwise relationships. Numerous studies 
have utilized them as a platform for deriving comprehensive tran- 
scriptional, metabolic, and physical interaction maps in several 
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organisms and contexts (e.g., Chatr-Aryamontri et al., 2013; 
Franceschini et al., 2013; Wong et al., 2012). Their application 
has also proven invaluable for deciphering regulatory relation- 
ships in transcriptional circuits, for studying their properties 
upon perturbation, and for connecting physiological responses 
and diseases to their molecular underpinnings (e.g., Kim et al., 
2012; Watson et al., 2013; Yang et al., 2014). 
Key to our approach is the premise that the distinct profiles of 
splicing changes caused by perturbation of regulatory factors 
depend on the functional bearings of those factors and can, 
therefore, be used as proxies for inferring functional relation- 
ships. We derive  a  network  that  recapitulates  the  topology 
of known splicing complexes and provides an extensive map 
of >500 functional associations among ~200 splicing factors 
(SFs). We use this network to identify general and particular 
mechanisms of AS regulation and to identify key SFs that 
mediate the effects on AS of perturbations induced by iron 
(see accompanying manuscript by Tejedor et al., 2014, in this 
issue of Molecular Cell) or by antitumor drugs targeting compo- 
nents of the splicing machinery. Our study offers a unique com- 
pendium of functional interactions among SFs, a discovery tool 
for coupling cell-perturbing stimuli to splicing regulation, and 
an expansive view of the splicing regulatory landscape and its 
organization. 
	  
RESULTS 
	  
Results from a genome-wide siRNA screen to identify regulators 
of Fas/CD95 AS revealed that knockdown of a significant 
fraction of core SFs (defined as proteins identified in highly puri- 
fied spliceosomal complexes assembled on model, single-intron 
pre-mRNAs; Wahl et al., 2009) caused changes in Fas/CD95 
exon 6 inclusion (Tejedor et al., 2014). The number of core fac- 
tors involved and the extent of their regulatory effects exceeded 
those of classical splicing regulatory factors like SR proteins or 
hnRNPs. To systematically evaluate the contribution of different 
classes of splicing regulators to AS regulation, we set up a 
screen in which we assessed the effects of  knockdown  of 
each individual factor on 38 ASEs relevant for cell proliferation 
and/or apoptosis (Figures 1A and 1B). The ASEs were selected 
due to their clear impact on protein function and their docu- 
mented biological relevance (see Table S1 available online). A 
library of 270 siRNA pools (Table S2) was used, corresponding 
to genes encoding core spliceosomal components as well as 
auxiliary regulatory SFs and factors involved in other RNA-pro- 
cessing steps, including RNA stability, export, or polyadenyla- 
tion. In addition, 40 genes involved in chromatin structure mod- 
ulation were included,  to probe for possible  functional links 
between chromatin and splicing regulation (Luco et al., 2011). 
The siRNA pools were individually transfected in biological 
triplicates in HeLa cells using a robotized procedure (Supple- 
mental Experimental Procedures). Seventy-two hours posttrans- 
fection, RNA was isolated, cDNA libraries generated using oligo- 
dT and random primers, and the patterns of splicing probed 
by PCR using primers flanking each of the alternatively spliced 
regions (Figure 1A). PCR products were resolved by high- 
throughput capillary electrophoresis (HTCE) and the ratio be- 
tween isoforms calculated as the percent spliced in (PSI) index 
(Katz et al., 2010), which represents the percentage of exon 
inclusion/alternative splice site usage. Knockdowns of factors 
affecting one ASE (Fas/CD95) were also validated with siRNA 
pools from a second library and by a second independent 
technique (Illumina HiSeq sequencing; Tejedor et al., 2014). 
Conversely, the effects of knocking down core SFs (P14, 
SNRPG, and SF3B1) on the ASEs were robust when different 
siRNAs and RNA purification methods were used (Figure S1A). 
Several pieces of evidence indicate that the changes in AS are 
not due to the induction of cell death upon depletion of essential 
SFs. First, cell viability was not generally compromised after 
72 hr of knockdown of 13 individual core SFs (Figure S1C). Sec- 
ond, cells detached from the plate were washed away before 
RNA isolation. Third, splicing changes upon induction of 
apoptosis with staurosporine were distinct from those observed 
upon knockdown of SFs (Figure S1D). 
Overall the screen generated a total of 33,288 PCR data 
points. These measurements provide highly robust and sensitive 
estimates of the relative use of competing splice sites. Figure 1D 
shows the spread of the effects of knockdown for all the factors 
in the screen for the ASEs analyzed. Three events (VEGFA, SYK, 
and CCND1) were excluded from further analysis, because they 
were not affected in the majority of the knockdowns (median ab- 
solute DPSI <1, Figure 1D). From these data we generated, for 
every knockdown condition, a perturbation profile that reflects 
its impact across the 35 ASEs in terms of the magnitude and di- 
rection of the change. Figures 1E and 1F show examples of such 
profiles and the relationships between them: in one case, knock- 
down of CDC5L or PLRG1 generates very similar perturbation 
profiles (upper diagrams in Figures 1E and 1F), consistent with 
their well-known physical interactions within the PRP19 complex 
(Makarova et al., 2004). In contrast, the profiles associated with 
the knockdown of SNRPG and DDX52 are to a large extent 
opposite to each other (lower diagrams in Figures 1E and 1F), 
suggesting antagonistic functions. Perturbation profiles and 
relationships between factors were not significantly changed 
	  
Figure 1.  Comprehensive Mapping of Functional Interactions between SFs in ASEs Implicated in Cell Proliferation and Apoptosis 
(A) Flowchart of the pipeline for network generation. See main text for details. 
(B) Genes with ASEs relevant for the regulation of cell proliferation and/or apoptosis used in this study. 
(C) Examples of HTCE profiles for FAS/CD95 and CHEK2 ASEs under conditions of knockdown of the core SF SF3B1. Upper panels show the HTCE profiles, 
lower panels represent the relative intensities of the inclusion and skipping isoforms. PSI values indicate the median and standard deviation of three independent 
experiments. 
(D) Spread of PSI changes observed for each of the events analyzed in this study upon the different knockdowns. 
(E) Examples of splicing perturbation profiles for different knockdowns. The profiles represent change toward inclusion (>0) or skipping (<0) for each ASE upon 
knockdown of the indicated factors, quantified as a robust Z score (see Experimental Procedures). 
(F) Robust correlation estimates and regression of the perturbation profiles of strongly correlated (PLRG1 versus CDC5L, upper panel) or anticorrelated (DDX52 
versus SNRPG, lower panel) factors. See also Figures S1 and S2, Table S1, and Table S2. 
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Figure 2. Coordinated Regulation of Splicing Events by Coherent Subsets of SFs 
(A) Heatmap representation of the results of the screen. ASEs used in this study are on the x axis, while knockdown conditions on the y axis. Data are clustered on 
both dimensions (ward linkage, similarity measure based on Pearson correlation). Information about ASEs, (a) type (ce, cassette exon; 5ss, alternative 5’ splice 
site; me, mutually exclusive exon; complex, multiexonic rearrangement; 3ss, alternative 3’ splice site; ir, intron retention) and (b) involvement in apoptosis and/or 
cell proliferation regulation, as well as information on the category of genes knocked down, is color coded. 
(B) Boxplot representation of the mean absolute Z score of AS changes induced by the knockdown of particular classes of factors, including core and noncore 
SFs, other RNA processing factors, and chromatin remodeling factors. Median and spread (interquartile range) of AS changes of mock siRNA conditions are 
represented as a green line and box, respectively. 
(C) As in (B) for spliceosomal factors that assemble early and stay as detectable components through the spliceosome cycle; factors that are present only 
transiently at early, mid, or late stages of assembly; and components of the exon junction complex (EJC). 
See also Figure S3, Table S2, Table S3, and Table S4. 
	  
when knockdown of a subset of factors was carried out for 48 hr 
(Figure S2A), arguing against AS changes being the conse- 
quence of secondary effects of SF knockdown in these cases 
(see also below the discussion on IK/SMU1). 
	  
Pervasive and Distinct Effects of Core Spliceosome 
Components on Alternative Splicing Regulation 
The output of the screening process is summarized in the heat- 
map of Figure 2A. Three main conclusions can be derived from 
these results. First, a large fraction of the SF knockdowns have 
noticeable but distinct effects on AS, indicating that knockdown 
of many components of the spliceosome causes switches in 
splice site selection, rather than a generalized inhibition of 
splicing of every intron. Second, a substantial fraction of AS 
changes correspond to higher levels of alternative exon inclu- 
sion, again arguing against simple effects of decreasing splicing 
activity upon knockdown of general SFs, which would typically 
favor skipping of alternative exons that often harbor weaker 
splice sites. These observations suggest extensive versatility 
of the effects of modulating the levels of SFs on splice site
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selection. Third, despite the diversity of the effects of SF knock- 
downs on multiple ASEs, similarities can also be drawn (Fig- 
ure 2A). For example, a number of ASEs relevant for the control 
of programmed cell death (e.g., Fas, APAF1, CASP9, or MCL1) 
cluster together and are similarly regulated by a common set 
of core spliceosome components. This observation suggests 
coordinated regulation of apoptosis by core factors, although 
the functional effects of these AS changes appear to be com- 
plex (Figure S3A). Another example is two distinct ASEs in the 
fibronectin gene (cassette exons EDA and EDB, of paramount 
importance to control aspects of development and cancer pro- 
gression; Muro et al., 2003) which cluster close together, sug- 
gesting common mechanisms of regulation of the ASEs in this 
locus. 
To explore the effects of different classes of SFs on AS regu- 
lation, we first grouped them in four categories: genes coding 
for core spliceosome components, noncore SFs/regulators, 
RNA-processing factors not directly related to splicing, and 
chromatin-related factors. Core SFs display the greater spread 
and average magnitude of effects, followed by noncore SFs (Fig- 
ure 2B). Factors related with chromatin structure and remodeling 
showed a narrower range of milder effects (Figure 2B), although 
their values were clearly above the range of changes observed in 
mock knockdown samples. Of interest, knockdown of core fac- 
tors leads to stronger exon skipping effects, while noncore SFs 
and other RNA processing and chromatin-related factors show 
more balanced effects (Figures S3B and S3C). 
To further dissect the effects of core components, we sub- 
divided them into four categories depending on the timing and 
duration of their recruitment to splicing complexes during 
spliceosome assembly (Wahl et al., 2009): (1) persistent compo- 
nents (e.g., 17S U2 snRNPs, Sm proteins) that enter the assem- 
bly process before or during complex A formation and remain 
until completion of the reaction, (2) transient early components 
that join the reaction prior to B complex activation but are scarce 
at later stages of the process, (3) transient middle components 
joining during B-act complex formation, and (4) transient late 
components that are only present during or after C complex for- 
mation. Our results indicate that knockdowns of factors that 
persist during spliceosome assembly cause AS changes of 
higher magnitude than those caused by knockdowns of transient 
factors involved in early spliceosomal complexes, which in turn 
are stronger and more dispersed than those caused by factors 
involved in middle complexes and in complex C formation or cat- 
alytic activation (Figure 2C). As observed for core factors in gen- 
eral, knockdown of persistent factors tends to favor skipping, 
while the effects of knockdown of more transient factors are 
more split between inclusion and skipping (Figures S3B and 
S3C). 
Interestingly, knockdowns of components of the exon junction 
complex (EJC) display a range of effects that resembles those of 
transient early or mid splicing complexes (Figure 2C). These re- 
sults are in line with recent reports documenting effects of EJC 
components in AS, in addition to their standard function in post- 
splicing processes (Ashton-Beaucage et al., 2010). 
To test whether the knockdown of core factors causes a gen- 
eral inhibition of splicing, we measured the levels of introns (both 
in constitutive and alternatively spliced regions) relative to exons 
in four genes, upon the knockdown of four SFs (BRR2, SF3B1, 
SNRPG, and SLU7). The results shown in Figure 3 reveal a 
complex picture in which retention of certain introns is clearly 
increased and retention of other introns is very mild, and there 
is even one case (the two introns flanking the fibronectin EDI 
alternative exon) in which the low levels of intron detected under 
control conditions are reduced upon knockdown of core SFs 
(notably, this ASE typically displays a distinct pattern of AS 
upon knockdown of core SFs, Figure 2A). Therefore, rather 
than a general uniform inhibition of splicing, reduction in the 
levels of core SFs induces differential effects in different introns, 
a concept reminiscent of the differential effects observed for 
antitumor drugs targeting core components like SF3B1 (Bonnal 
et al., 2012). 
	  
Reconstruction of a Functional Network of Splicing 
Factors 
To systematically and accurately map the functional relation- 
ships of SFs on AS regulation, we quantified the similarity be- 
tween AS perturbation profiles for every pair of factors in our 
screen using a robust correlation estimate for the effects of the 
factors’ knockdowns across the ASEs. This measure captures 
the congruence between the shapes of perturbation profiles, 
while it does not take into account proportional differences in 
the magnitude of the fluctuations. Crucially, it discriminates be- 
tween biological and technical outliers and is resistant to distort- 
ing effects of the latter (Supplemental Experimental Procedures). 
We next employed glasso, a regularization-based algorithm 
for graphical model selection (Friedman et al., 2008; Supple- 
mental  Experimental  Procedures),  to  reconstruct  a  network 
from these correlation estimates (Figures 4A and S4). Glasso 
seeks a parsimonious network model for the observed correla- 
tions. This is achieved by specifying a regularization parameter, 
which serves as a penalty that can be tuned in order to control 
the number of inferred connections (network sparsity) and there- 
fore the false discovery rate (FDR) of the final model. For a given 
regularization parameter, both the number of inferred connec- 
tions and the FDR are a decreasing function of the number of 
ASEs assayed (Figure 4B). Random sampling with different sub- 
sets of the real or reshuffled versions of the data indicates that 
network reconstruction converges to ~500 connections with a 
FDR <5% near 35 events (Figure 4B), implying that analysis of 
additional ASEs in the screening would have only small effects 
on network sparsity and accuracy. 
The complete network of functional interactions among the 
screened factors is shown in Figure 4A. It is comprised of 196 
nodes representing screened factors and 541 connections 
(average degree 5.5), of which 518 correspond to positive and 
23 to negative functional associations. The topology of the re- 
sulting network has several key features. First, two classes of 
factors are easily distinguishable. The first class encompasses 
factors that form densely connected clusters comprised  of 
core spliceosomal components (Figure 4A). Factors physically 
linked within U2 snRNP and factors functionally related with U2 
snRNP activity, and with the transition from complex A to B, 
form a tight cluster (orange nodes in the inset of Figure 4A). An 
adjacent but distinct highly linked cluster corresponds mainly 
to factors physically associated within U5 snRNP or the U4/5/6
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Figure 3. Variety of Effects of Knockdown of Core SFs on Intron Retention 
(A–D) Real-time quantification of AS, intron retention, and gene expression for four genes included in the splicing network (FAS, A; MCL1, B; CHEK2, C; and FN1, 
D) upon knockdown of four core spliceosomal components (BRR2, SF3B1, SNRPG, and SLU7). In each of the panels, the graphs represent the following: top, 
scheme of genomic locations, AS patterns, and amplicons used; middle top, quantification of fold changes in expression of the different isoforms or introns 
(indicated by the color code) compared to mock siRNA conditions; middle bottom, relative levels of the different isoforms or introns (indicated by the color code) 
compared to HPRT1 housekeeping gene mRNAs; and bottom, AS changes measured by HTCE. PSI values are indicated. For all assays, values represent the 
mean, and error bars the standard deviation of three independent biological replicas. 
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tri-snRNP (blue nodes in Figure 4A, inset). Factors in these clus- 
ters and their mutual links encompass 23% of the network nodes 
but 63% of the total inferred functional associations (average 
degree 14.5). A second category includes factors that form 
a periphery of  lower  connectivity  that  occasionally  projects 
to the core. This category includes many of the classical 
splicing regulators (e.g., SR proteins, hnRNPs) as well as several 
chromatin factors. An intermediate category—more densely in- 
terconnected but not reaching the density of interactions of 
the central modules—includes multiple members of the RNA- 
dependent DEAD/X box helicase family. While the number of 
connections (degree) is significantly higher for core spliceosomal 
factors in general (Figure 4C), this is especially clear for factors 
that represent persistent components of splicing complexes 
along the assembly pathway (Figures 4D and 4E). Persistent 
factors are particularly well connected to each other (50% of 
the possible functional connections are actually detected, Fig- 
ure 4E). Factors that belong to consecutive complexes are signif- 
icantly more linked to each other than factors that belong to early 
and late complexes, and factors that transiently assemble to- 
ward the final stages of spliceosome assembly display the least 
number of connections (Figures 4D and 4E). 
Collectively, these results indicate that core SFs, particularly 
those that persist during assembly, display highly related func- 
tions in splice site recognition and fluctuations in their levels or 
activities have related consequences on the modulation of splice 
site choice. Of the observed connections, 20% can be attributed 
to known physical interactions and 82% of these are among core 
components (Figure 4A). Examples include tight links between 
the two subunits of U2AF, between the interacting partners 
PLRG1 and CDC5L or IK and SMU1. We estimate that about 
50% of the functional links detected in our network could be pre- 
dicted by previous knowledge of the composition or function of 
splicing complexes. 
Of relevance, a substantial number of the functional associa- 
tions closely recapitulate the composition and even—to some 
extent—the topology of known spliceosomal complexes (Fig- 
ure S4; see also below and Discussion). These observations 
suggest that differences in the sensitivity of ASEs to SF pertur- 
bations reflect the specific role of these factors in the splicing 
process. Conversely, these results warrant the use of splicing 
perturbation profiles as proxies for inferring physical or func- 
tional links between factors in the splicing process. 
	  
Generality of the Functional Interactions in the AS 
Regulation Network 
The above network was derived from variations in 35 ASEs 
selected because of their relevance for cell proliferation and 
apoptosis, but they represent a heterogeneous collection of AS 
types and, possibly, regulatory mechanisms. To identify func- 
tional connections persistent across AS types, we undertook a 
subsampling approach. We sampled subsets of 17 from the 
original 35 ASEs and iteratively reconstructed the network of 
functional associations from each subset (see Supplementary 
methods). Following 10,000 iterations, we asked how many 
functional connections were recovered in at least 90% of the 
sampled networks. The retrieved set of connections are shown 
in Figure 5A and they can be considered to represent a ‘‘basal’’ 
or indispensable splicing circuitry that captures close similarities 
in function between SFs regardless of the subset of splicing 
substrates considered. The majority of these connections corre- 
spond to links between core components, with modules corre- 
sponding to major spliceosomal complexes. For example, the 
majority of components of U2 snRNP constitute the most prom- 
inent of the core modules (Figure 5A). Strikingly, the module 
is topologically subdivided in two submodules, the first corre- 
sponding to components of the SF3a and SF3b complexes 
and the second corresponding to proteins in the Sm complex. 
The connectivity between U2 snRNP components remarkably 
recapitulates known topological features of U2 snRNP organiza- 
tion, including the assembly of SF3a/b complexes in stem loops 
I and II and the assembly of the Sm ring in a different region 
of the U2 snRNA (Behrens et al., 1993) (Figures 5A and S4). 
That the connectivity between components derived from as- 
sessing the effects on AS of depletion of these factors correlates 
with topological features of the organization of the snRNP further 
argues that the functions in splice site selection are tightly linked 
to the structure and function of this particle, highlighting the 
potential resolution of our approach for identifying meaningful 
structural and mechanistic links. 
A second prominent ‘‘core’’ module corresponds to factors 
known to play roles in conformational changes previous to/ 
concomitant with catalysis in spliceosomes from yeast to hu- 
man, including PRP8, PRP31 or U5-200. Once again some of 
the topological features of the module are compatible with phys- 
ical associations between these factors (e.g., PRP8 with PRP31 
or U5-116K or PRP31 with C20ORF14). That knockdown of 
these late-acting factors, which coordinate the final steps of 
the splicing process (Bottner et al., 2005; Ha¨ cker et al., 2008; 
Wahl et al., 2009), causes coherent changes in splice site selec- 
tion strongly argues that the complex process of spliceosome 
assembly can be modulated at late steps, or even at the time 
of catalysis, to affect splice site choice. Other links in  the 
‘‘core’’ network recapitulate physical interactions, including the 
aforementioned modules involving the two subunits of the 3’ 
splice site-recognizing factor U2AF, the interacting partners 
PLRG1 and CDC5L and IK and SMU1. 
To further evaluate the generality of our approach, we tested 
whether the functional concordance derived from our network 
analysis and from the iterative selection of a ‘‘core’’ network 
could be recapitulated in a different cell context and genome- 
wide. We focused our attention in the strong functional asso- 
ciation between  IK and  SMU1, two factors that have  been 
described as associated with complex B and its transition to 
Bact (Bessonov et al., 2008) (Figure 5A). Analysis of the effects 
of knockdown of these factors in the same sets of ASEs in 
HEK293 cells revealed a similar set of associations, despite 
the fact that individual events display different splicing ratios 
upon IK/SMU1 knockdown in this cell line compared to HeLa 
(Figures 5B and 5C). To explore the validity of this functional 
association in a larger set of splicing events, RNA was isolated 
in biological triplicates from HeLa cells transfected with 
siRNAs against these factors, and changes in AS were assessed 
using genome-wide splicing-sensitive microarrays. The results 
revealed a striking overlap between the effects of IK and 
SMU1 knockdown, both on gene expression changes and on
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AS changes (61% overlap, p < 1E-20) covering a wide range of 
gene expression levels, fold differences in isoform ratios and AS 
types (Figures 5D–5F, S5B, and S5C). The overlap was much 
more limited with RBM6, a splicing regulator (Bechara et al., 
2013) located elsewhere in the network. These results validate 
the strong functional similarities between IK and SMU1 detected 
in our analysis. The molecular basis for this link could be ex- 
plained by the depletion of each protein (but not their mRNA) 
upon knockdown of the other factor, consistent with formation 
of a heterodimer of  the two proteins and  destabilization  of 
one partner after depletion of the other (Figure S5A). Notably, 
the best correlation between the effects of these factors was be- 
tween IK knockdown for 48 hr and SMU1 knockdown for 72 hr, 
perhaps reflecting a stronger functional effect of IK on AS regu- 
lation (Figures S2B and S2D). 
Gene ontology analysis revealed a clear common enrichment 
of AS changes in genes involved in cell death and survival (Fig- 
ure S5D), suggesting that IK/SMU1 could play a role in the 
control of programmed cell death through AS. To evaluate this 
possibility, we tested the effects of knockdown of these factors, 
individually or combined, on cell proliferation and apoptotic as- 
says. The results indicated that their depletion activated cleav- 
age of PARP, substantially reduced cell growth, and increased 
the fraction of cells undergoing apoptosis (Figures S5E–S5G). 
We conclude that functional links revealed by the network can 
be used to infer common mechanisms of splicing regulation 
and provide insights into the biological framework of the regula- 
tory circuits involved. 
	  
Ancillary Functional Network Interactions Reveal 
Alternative Mechanisms of AS Regulation 
The iterative generation of networks from subsets of ASEs ex- 
plained above could, in addition to identifying general functional 
interactions, be used to capture functional links that are specific 
to particular classes of events characterized by distinct regula- 
tory mechanisms. To explore this possibility, we sought the set 
of functional connections that are robustly recovered in a signif- 
icant fraction of ASEs subsets but are absent in others (see 
Supplemental Experimental Procedures). Figure 6A shows the 
set of such identified interactions, which therefore represents 
specific functional links that only emerge when particular sub- 
sets of ASEs are considered. The inset represents graphically 
the results of principal component analysis (PCA) showing the 
variability in the strength of these interactions depending on 
the presence or absence of different ASEs across the subsam- 
ples. The most discriminatory set of ASEs for separating these 
interactions is also shown (see also Figure S6). While this anal- 
ysis may be constrained by the limited number of events 
analyzed and higher FDR due to multiple testing, it can provide 
a valuable tool for discovering regulatory mechanisms underly- 
ing specific classes of ASEs as illustrated by the example 
below. 
A synergistic link was identified between hnRNP C and U2AF1 
(the 35 kDa subunit of U2AF, which recognizes the AG dinucleo- 
tide at 3’ splice sites) for a subset of ASEs (Figures 6A and S6A). 
We explored  a possible relationship  between the effects of 
knocking down these factors and the presence of consensus 
hnRNP C binding sites (characterized by stretches of uridine res- 
idues) or 3’ splice site-like motifs in the vicinity of the regulated 
exons. The results revealed a significant correlation between 
the two factors (0.795), associated with the presence of compos- 
ite elements comprised of putative hnRNP C binding sites within 
sequences conforming to a 3’ splice site motif (see Experimental 
Procedures) upstream and/or downstream of the regulated 
exons (Figures 6B and S6B). No such correlation was observed 
for ASEs lacking these sequence features (Figures 6C and S6C). 
These observations are in line with results from a recent report 
revealing that hnRNP C prevents exonization of Alu elements 
by competing the binding of U2AF to Alu sequences (Zarnack 
et al., 2013). Our results extend these findings by capturing func- 
tional relationships between hnRNP C and U2AF in ASEs that 
harbor binding sites for these factors in the vicinity of the regu- 
lated splice sites, both inside of Alu elements or independent 
of them (Figures 6B and 6D). Our data are compatible with a 
model in which uridine-rich and 3’ splice site-like sequences 
sequester U2AF away from the regulated splice sites, causing 
alternative exon skipping, while hnRNP C displaces U2AF 
away from these decoy sites, facilitating exon inclusion. In this 
model, depletion of U2AF and hnRNP C are expected to display 
the same effects in these ASEs, as observed in our data (Figures 
6B and 6D). In contrast, in ASEs in which hnRNP C binding sites 
are located within the polypyrimidine tract of the 3’ splice site of 
the regulated exon, the two factors display antagonistic effects 
(Figures 6C and 6D), as expected from direct competition be- 
tween them at a functional splice site. This example illustrates 
the potential of the network approach to identify molecular 
mechanisms of regulation on the basis of specific sequence fea- 
tures and the interplay between cognate factors. 
	  
	  
Figure 4.  Functional Splicing Regulatory Network 
(A) Graphical representation of the reconstructed splicing network. Nodes (circles) correspond to individual factors and edges (lines) to inferred functional as- 
sociations. Positive or negative functional correlations are represented by green or red edges, respectively. Edge thickness signifies the strength of the functional 
interaction, while node size is proportional to the overall impact (median Z score) of a given knockdown in the regulation of AS. Node coloring depicts the 
network’s natural separation in coherent modules (see Supplemental Experimental Procedures). Known physical interactions as reported in the STRING 
database (Franceschini et al., 2013) are represented in black dotted lines between factors. The inset is an expanded view of factors in the U2 and U4/5/6 snRNP 
complexes. 
(B) Number of recovered network edges using actual or randomized data sets (red and green points respectively) as a function of the number of ASEs used. Lines 
represent the best fit curves for the points. 
(C and D) Network degree distribution. The plots represent the cumulative frequency of the number of connections (degree) for different classes of factors (as in 
Figures 2B and 2C). 
(E) Functional crosstalk between different categories of spliceosome components. Values represent the fraction of observed functional connections out of the 
total possible connections among factors that belong to the different categories: persistent, P; transient early, E; transient mid, M; or transient late, L factors. See 
also Figure S4E and Table S5. 
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Figure 5. Core Network Involved in AS Regulation 
(A) Graphical representation of the functional connections present in at least 90% of 10,000 networks generated by iterative selection of subsets of 17 out of the 
35 ASEs used to generate the complete network. Network attributes represented as in Figure 4A. Known spliceosome complexes are highlighted by shadowed 
areas (U1 snRNP, blue; U2 snRNP, yellow; SM proteins, green; and tri-snRNP proteins, red). 
(B and C) Consistency of inferred functional interactions in different cell lines. Knockdown of IK or SMU1 was carried out in parallel in HeLa (B) or HEK293 cells (C), 
and changes for the 35 ASEs were analyzed by RT-PCR and HTCE. Robust correlation estimates and regression for the AS changes observed in IK versus SMU1 
knockdowns are shown for each of the cell lines. 
(D) Venn diagrams of the overlap between the number of gene expression changes upon IK, SMU1, or RBM6 knockdowns. 
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Figure S5. 
	  
	  
Mapping Drug Targets within the Spliceosome 
Another application of our network analysis is to identify possible 
targets within the splicing machinery of physiological or external 
(e.g., pharmacological) perturbations that produce changes in 
AS that can be measured using the same experimental setting. 
The similarity between profiles of AS changes induced by such 
perturbations and the knockdown of particular factors can help 
to uncover SFs that mediate their effects. To evaluate the poten- 
tial of this approach, cells were treated with drugs known to 
affect AS decisions and the patterns of changes in the 35 
ASEs induced by these treatments were assessed by the same 
robotized procedure for RNA isolation and RT-PCR analysis 
used to locate their position within the network. 
The results indicate that structurally similar drugs like Spli- 
ceostatin A (SSA) and Meayamycin cause AS changes that 
closely resemble the effects of knocking down components of 
U2 snRNP (Figure 7A), including close links between these drugs 
and SF3B1, a known physical target of SSA (Kaida et al., 2007; 
Hasegawa et al., 2011) previously implicated in mediating the ef- 
fects of the drug through alterations in the AS of cell cycle genes 
(Corrionero et al., 2011). Of interest, changes in AS of MCL1 
(leading to the production of the proapoptotic mRNA isoform) 
appear as prominent effects of both drugs (Figure 7B), confirm- 
ing and extending recent observations obtained using Meaya- 
mycin (Gao et al., 2013) and suggesting that this ASE can play 
a key general role in mediating the antiproliferative effects of 
drugs that target core splicing components like SF3B1 (Bonnal 
et al., 2012). A strong link is also captured between each of the 
drugs and PPIH (Figure 7A), a peptidyl-prolyl cis-trans isomerase 
which has been found to be associated with U4/5/6 tri-snRNP 
(Horowitz et al., 1997; Teigelkamp et al., 1998) but had not 
been implicated directly in 3’ splice site regulation. Indeed, the 
network indicates a close relationship between PPIH and multi- 
ple U2 snRNP components, particularly in the SF3a and SF3b 
complexes, further arguing that PPIH plays a role in 3’ splice 
site definition closely linked to branchpoint recognition by U2 
snRNP. Treatment of the cells with the Clk (Cdc2-like) kinase 
family inhibitor TG003, which is also known to modulate AS (Mur- 
aki et al., 2004) and causes changes in ASEs analyzed in our 
network (Figure 7B), led to links with a completely different set 
of SFs (Figure 7A), attesting to the specificity of the results. These 
data confirm the potential of the network analysis to identify 
bona fide SF targets of physiological or pharmacological pertur- 
bations and further our understanding of the the underlying mo- 
lecular mechanisms of regulation. 
	  
DISCUSSION 
	  
The combined experimental and computational approach 
described in this manuscript provides a rich source of informa- 
tion and a powerful toolset for studying the splicing process 
and its regulation. Similar approaches could be useful to system- 
atically capture information about other aspects of transcrip- 
tional or posttranscriptional gene regulation. The data provide 
comprehensive information about SFs (and some additional 
chromatin factors) relevant to understand the regulation of 35 
ASEs important for cell proliferation and apoptosis. Second, 
the network analysis reveals functional links between SFs, which 
in some cases are based upon physical interactions. The recon- 
struction of the known topology of some complexes (e.g., U2 
snRNP) by the network suggests that the approach captures 
important aspects of the operation of these particles and 
therefore has the potential to provide novel insights into the 
composition and intricate workings of multiple Spliceosomal 
subcomplexes. Third, the network can serve as a resource for 
exploring mechanisms of AS regulation induced by perturba- 
tions of the system, including genetic manipulations, internal 
or external stimuli, or exposure to drugs. As an example, the 
network was used in the accompanying manuscript by Tejedor 
et al. (2014) to identify a link between AS changes induced by 
variations in intracellular iron and the function of SRSF7, which 
can be explained in terms of iron-induced changes in the RNA 
binding and splicing regulatory activity of this zinc-knuckle-con- 
taining SR protein. Other examples include (1) the identification 
of the extensive regulatory overlap between the interacting pro- 
teins IK/RED and SMU1, relevant for the control of programmed 
cell death; (2) evidence for a general role of uridine-rich hnRNP C 
binding sequences (some associated with transposable ele- 
ments; Zarnack et al., 2013) in the regulation of nearby alterna- 
tive exons via antagonism with U2AF; and (3) delineation of U2 
snRNP components and other factors, including PPIH, that are 
functionally linked to the effects of antitumor drugs on AS. 
Our data reveal changes of AS regulation mediated either by 
core splicing components or by classical regulatory factors like 
proteins of the SR and hnRNP families. While the central core 
of functional links is likely to operate globally, alternative config- 
urations (particularly in the periphery of the network) are likely to 
emerge if similar approaches are applied to other cell types, 
genes, or biological contexts. We report considerable versatility 
in the effects of core spliceosome factors on alternative spicing. 
Precedents exist for a role of core SFs on the regulation of 
splicing efficiency or splice site selection in yeast, Drosophila, 
and mammalian cells (Clark et al., 2002; Park et al., 2004; Pleiss 
et al., 2007; Saltzman et al., 2011). Despite their assumed gen- 
eral roles in the splicing process, depletion or mutation of 
particular core factors led to differential splicing effects in these 
studies, and at least in some cases the differential effects could 
be attributed to particular features of the regulated pre-mRNAs. 
For example, Clark et al. (2002) found that the core components 
Prp17p and Prp18p are dispensable for splicing of yeast introns 
with short branchpoint to 3’ splice site distances. Pleiss et al. 
(2007) found that introns of  yeast  ribosome  protein  genes 
are particularly sensitive to mutation of various core factors, 
including two DEAD/X box family of RNA helicases (PRP2 and 
PRP5) involved in spliceosome conformational transitions and 
PRP8, a highly conserved protein involved in catalytic activation 
	  
(E) Venn diagrams of the overlap between the number of AS changes upon knockdown of IK, SMU1, or RBM6. 
(F) Distribution of ASEs in the Affymetrix array platform (upper panel) and distribution of the AS changes observed upon IK (lower left) or SMU1 (lower right) 
knockdown. p values correspond to the difference between the distribution of AS changes upon knockdown and the distribution of ASEs in the array. See also  
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Figure 6. Variable Functional Interactions Extracted from Networks Generated from Subsets of ASEs 
(A) Network of ancillary functional connections characteristic of subsets of ASEs. Lines link SFs that display functional similarities in their effects on subsets of 
ASEs. Line colors indicate the positions of the interactions in the PCA shown in the inset, which captures the different relative contributions of the ASEs in defining 
these connections (see also Figure S6 and Experimental Procedures). For clarity, only the top ten discriminatory ASEs are shown. 
(B and C) Correlation values and regression for the effects of U2AF1 versus HNRPC knockdowns for ASEs in the presence (B) or absence (C) of upstream 
composite HNRPC binding/3’ splice site-like elements. 
	  
(legend continued on next page) 
Figure  S6. 
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(Collins and Guthrie, 1999; Mozaffari-Jovin et al., 2012). Distinct 
effects of the mutations on different ribosomal genes were also 
observed, arguing again for specific effects on splicing of certain 
genes. DEAD/H box proteins as well as components of U1, U2, 
and U4/6 snRNP were found to modulate particular ASEs in an 
RNAi screen of RNA binding proteins in Drosophila cells (Park 
et al., 2004). In contrast with the standard function of classical 
splicing regulators acting through cognate binding sites specific 
to certain target RNAs, core factors could both carry out general, 
essential functions for intron removal and in addition display reg- 
ulatory potential if their levels become limiting for the function of 
complexes, leading to differences in the efficiency or kinetics of 
assembly on alternative splice sites. This could be the case for 
the knockdown of SmB/B0, a component of the Sm complex pre- 
sent in most spliceosomal snRNPs, which leads to autoregula- 
tion of its own pre-mRNA as well as to effects on hundreds of 
other ASEs, particularly in genes encoding RNA processing fac- 
tors (Saltzman et al., 2011). 
The results of our genome-wide siRNA screen for regulators of 
Fas AS (Tejedor et al., 2014) provide unbiased evidence that an 
extensive number of core SFs have the potential to contribute to 
the regulation of splice site selection. This is, in fact, the most 
populated category of screen hits. Similarly, the results of our 
network highlight coherent effects on alternative splice site 
choice of multiple core components, revealing also that the 
extent of their effects on alternative splice site selection can be 
largely attributed to the duration and order of their recruitment 
in the splicing reaction. 
Remarkably, effects on splice site selection are associated 
with depletion not only of complexes involved in early splice 
site recognition but also of factors involved in complex B forma- 
tion or even in catalytic activation of fully assembled spliceo- 
somes. While particular examples of AS regulation at the time 
of the transition from complex A to B and even at later steps 
had been reported (House and Lynch, 2006; Bonnal et al., 
2008; Lallena et al., 2002), our results indicate that the implication 
of late factors is quite general. Such links, e.g., those involving 
PRP8 and other interacting factors closely positioned near the re- 
acting chemical groups at the time of catalysis, like PRP31 or U5 
200KD, are actually part of the persistent functional interactions 
that emerge from the analysis of any subsample of ASEs 
analyzed, highlighting their general regulatory potential in splice 
site selection. How can factors involved in late steps of the 
splicing process influence splice site choices? It is conceivable 
that limiting amounts of late spliceosome components would 
favor splicing of alternative splice site pairs harboring early com- 
plexes that can more efficiently recruit late factors, or influence 
the kinetics of conformational changes required for catalysis. In 
this context, the regulatory plasticity revealed by our network 
analysis may be contributed, at least in part, by the emerging real- 
ization that a substantial number of SFs contain disordered re- 
gions when analyzed in isolation (Korneta and Bujnicki, 2012; 
Chen and Moore, 2014). Such regions may be flexible to adopt 
different conformations in the presence of other spliceosomal 
components, allowing alternative routes for spliceosome assem- 
bly on different introns, with some pathways being more sensitive 
than others to the depletion of a general factor. 
Kinetic effects on the assembly and/or engagement of splice 
sites to undergo catalysis would be particularly effective if spli- 
ceosome assembly is not an irreversible process. Results of sin- 
gle molecule analysis are indeed compatible with this concept 
(Tseng and Cheng, 2008; Abelson et al., 2010; Hoskins et al., 
2011; Hoskins and Moore, 2012; Shcherbakova et al., 2013), 
thus opening the extraordinary complexity of conformational 
transitions and dynamic compositional changes of the spliceo- 
some as possible targets for regulation. Interestingly, while 
depletion of early factors tends to favor exon skipping, depletion 
of late factors causes a similar number of exon inclusion and 
skipping effects, suggesting high plasticity in splice site choice 
at this stage of the process. 
Given this potential, it is conceivable that modulation of the 
relative concentration of core components can function as a 
physiological mechanism for splicing regulation, for example 
during development and cell differentiation. Indeed, variations 
in the relative levels of core spliceosomal components have 
been reported (Wong et al., 2013). Furthermore, recent reports 
revealed the high incidence of mutations in core SFs in cancer. 
For example, the gene encoding SF3B1, a component of U2 
snRNP involved in branchpoint recognition, has been described 
as among the most highly mutated in myelodysplastic  syn- 
dromes (Yoshida et al., 2011), chronic lymphocytic leukemia 
(Quesada et al., 2012), and other cancers (reviewed in Bonnal 
et al., 2012), correlating with different disease outcomes. 
Remarkably, SF3B1 is the physical target of antitumor drugs 
like Spliceostatin A and—likely—Meayamycin, as captured by 
our study. These observations are again consistent with the 
idea that depletion, mutation, or drug-mediated inactivation of 
core SFs may not simply cause a collapse of the splicing pro- 
cess—at least under conditions of limited physical or functional 
depletion—but rather lead to changes in splice site selection that 
can contribute to physiological, pathological, or therapeutic out- 
comes. SF3B1 participates in the stabilization and proofreading 
of U2 snRNP binding to the branchpoint region (Corrionero et al., 
2011), and it is therefore possible that variations in the activity of 
this protein result in switches between alternative 3’ splice sites 
harboring branch sites with different strengths and/or flanking 
decoy binding sites. Similar concepts may apply to explain the 
effects of mutations in other SFs linked to disease, including, 
for example, mutations in PRP8 leading to retinitis pigmentosa 
(Pena et al., 2007). 
In summary, the data and methodological approaches pre- 
sented in this study provide a rich resource for understanding 
the function of the spliceosome and the mechanisms of AS regu- 
lation, including the identification of targets of physiological, 
pathological, or pharmacological perturbations within the com- 
plex splicing machinery. 
	  
(D)  Schematic  representation  of  the  distribution  of  composite  HNRPC  binding  sites/3’  splice  site-like  sequences  in  representative  examples  of 
the splicing events analyzed. The relative position of Alu elements in these regions is also shown. Genomic distances are drawn to scale. The di- 
rection of the arrows indicates up or downregulation of cassette exons upon knockdown of U2AF1 (black arrows) or HNRPC (white arrows). See also 
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Figure 7. Mapping the Effects of Pharmaco- logical Treatments to the Splicing Network 
(A) Functional connections of splicing inhibitory drugs with the splicing machinery. See text for details. 
(B) Splicing perturbation profiles for Spliceostatin A, Meayamycin, or TG003 treatments across the 35 ASEs analyzed	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EXPERIMENTAL  PROCEDURES 
	  
siRNA Library Transfection and mRNA Extraction 
HeLa cells were transfected in biological triplicates with siRNAs pools 
(ON TARGET plus smartpool, Dharmacon, Thermo Scientific) against 
270 splicing and chromatin remodeling factors (see Table S2). 
Endogenous mRNAs were purified 72 hr posttransfection by using oligo 
dT-coated 96-well plates (mRNA catcher PLUS, Life Technologies) 
following the man- ufacturer’s instructions.  RNA samples 
corresponding  to treatments with splicing arresting drugs were isolated 
with the Maxwell 16 LEV simplyRNA kit (Promega). 
	  
RT-PCR and High-Throughput Capillary Electrophoresis 
Cellular mRNAs were reverse transcribed using Superscript III Retro 
Tran- scriptase (Invitrogen, Life Technologies) following the 
manufacturer’s recom- mendations. PCR reactions for every individual 
splicing event analyzed were carried out using forward and reverse 
primers in exonic sequences flanking the alternatively spliced region of 
interest and further reagents provided in the GOTaq DNA polymerase kit 
(GoTaq, Promega). Primers used in this study are listed in Table S6. 
HTCE measurements for the different splicing isoforms were performed 
in 96-well format in a Labchip GX Caliper workstation (Caliper, Perkin 
Elmer) us- ing a HT DNA High Sensitivity LabChip chip (Perkin Elmer). 
Data values were obtained using the Labchip GX software analysis tool 
(version 3.0). 
	  
Quantification of AS Changes from HTCE Measurements 
Robust estimates of isoform ratios upon siRNA or pharmacological 
treatments were obtained using the median PSI indexes of the biological 
triplicates for each knockdown-AS pair. From this value xi the effect of 
each treatment was summarized as a robust Z score (Birmingham et al., 
2009): 
 
Robust   Sample   Correlation   Estimation 
Robust  correlation  estimation  is  based  on  an iterative  weighting  
algorithm  that  discriminates between technical outliers and reliable 
measure- ments with high leverage. The weighting for mea- surements 
relies on calculation of a reliability index that takes into account their 
cumulative influence on  correlation  estimates  of  the  complete  data 
set. Algorithmic details are provided in Supplemental Experimental 
Procedures. 
 
Network Reconstruction 
The process of network reconstruction relies on the regularization-based 
graphical lasso (glasso) algorithm for graphical model selection (Friedman 
et al., 2008). The glasso process for network reconstruction was 
implemented using the glasso R package by Jerome Friedman, Trevor 
Hastie, and Rob Tibshirani (http://statweb.stanford.edu/~tibs/glasso/). A 
detailed exposition of the algorithmic steps for network reconstruction and 
analysis, glasso, and its use for graphical model selection is provided in 
Supplemental Experimental Procedures. 
 
Principal Component Analysis of Ancillary Connections 
PCA for ancillary edges was performed using R-mode PCA (R function 
prin- comp). The input data set is the scaled 95 3 35 matrix containing the 
absolute average correlation for each of the 95 edges over the subsets of 
the 10,000 samples that included each of the 35 events. The coordinates 
for projecting the 95 edges are directly derived from their scores on the 
first two principal components. The arrows representing the top ten 
discriminatory events (based on the vector norm of the first two PC 
loadings) were drawn from the origin to the coordinate defined by the first 
two PC loadings scaled by a con- stant factor for display purposes. 
 
Splice Site Scoring, Identification of Probable HNRPC Binding Sites 
and Alu Elements 
For the identification and scoring of 3’ ss we used custom-built position 
weight 
matrices (PWMs) of length 21—8 intronic plus three exonic positions. 
The matrices were built using a set of human splice sites from constitutive, 
internal exons compiled from the hg19 UCSC annotation database 
(Karolchik et al., 2014). Background nucleotide frequencies were estimated 
from a set of strictly intronic regions. Threshold was set based  
 
 
on a FDR of 0.5/kbp of random in- tronic sequences generated using a 
second-order Markov chain of actual in- tronic regions. 
We considered as probable HNRPC binding sites consecutive stretches of 
U{4} as reported in Zarnack et al. (2013). Annotation of ALU elements 
was based on the RepeatMasker track developed by Arian Smit 
(http://www. repeatmasker.org) and the Repbase library (Jurka et al., 
2005). 
More  detailed  experimental  procedures  are  provided  
in  Supplemental Experimental Procedures. 
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Figure	  S1.	  Consistent	  profiles	  of	  AS	  changes	  and	  limited	  cell	  death	  induced	  by	  the	  
knockdown	  of	  core	  components	  using	  different	  siRNAs.	  	  A.	  AS	  perturbation	  profiles	  
obtained	  for	  depletion	  of	  SNRPG,	  P14	  or	  SF3B1	  using	  two	  different	  siRNAs	  .	  Robust	  
correlation	  between	  conditions	  and	  siRNA	  sequences	  used	   for	   factor	  depletion	  are	  
indicated.	  Positive	  Z-­‐scores	  indicate	  changes	  towards	  exon	  inclusion,	  negative	  values	  
indicate	   exon	   skipping.	   B.	   Knockdown	   efficiency	   for	   a	   subset	   of	   splicing	   factor	  
components.	  Western	  blot	  analyses	  of	  protein	  depletion	  upon	  siRNA	  treatment	  for	  6	  
	   	   	  
	  
spliceosome	  factors,	  for	  two	  of	  them	  two	  independent	  siRNA	  libraries,	  as	   indicated	  
in	   A.	   Depletion	   efficiency	  was	   calculated	   by	   quantifying	   the	   levels	   of	  western	   blot	  
signals	   using	   ImageQuant	   TL	   software	   (GE	   Healthcare	   Life	   sicences).	   	   C.	  
Quantification	   of	   cell	   death	   upon	   depletion	   of	   core	   spliceosomal	   components	   or	  
treatment	   with	   staurosporin.	   Data	   represents	   the	   percentage	   of	   normal,	   early	  
apoptotic,	   late	  apoptotic	  or	  necrotic	   cells	   analyzed	  by	   flow	  cytometry	   sorting	  after	  
staining	   with	   annexin	   V	   and	   propidium	   iodide.	   Values	   represent	   the	   mean	   and	  
standard	  deviation	  of	  3	  independent	  biological	  replicates.	  D.	  Induction	  of	  apoptosis	  
by	  staurosporine	  leads	  to	  AS	  changes	  distinct	  from	  those	  induced	  by	  the	  knock	  down	  
or	   core	   splicing	   factors.	   Perturbation	  profiles	  were	  measured	  after	  3	  or	  8	  hours	  of	  
staurosporin	   treatment	   (1	   mM)	   and	   compared	   with	   the	   perturbation	   profiles	  
obtained	  upon	  knockdown	  of	  IK,	  SMU1	  or	  SF3B1	  for	  72	  hours.	  	  
	  
Figure	   S2.	   Differences	   in	   knockdown	   conditions	   do	   not	   significantly	   alter	  
correlation	   values	  within	   the	   network.	  A.	  Perturbation	  profiles	   upon	   IK,	   SMU1	  or	  
SF3B1	   	   knockdown	   for	   24,	   48	   or	   72	   hours	   across	   the	   35	   splicing	   events	   used	   for	  
network	  generation.	  B.	  Perturbation	  profiles	  upon	  IK	  or	  SMU1	  depletion	  at	  48	  and	  72	  
hours,	  respectively.	  C.	  Overall	  effects	  in	  AS	  changes	  across	  the	  35	  events	  after	  24,	  48	  
or	   72	  hours	   of	   siRNA	   treatment.	   Box	  plots	   represent	   the	  median	   and	   spread	  of	   Z-­‐
scores	   of	   the	   effects	   across	   different	   events	   upon	   the	   knockdown	   of	   IK,	   SMU1	   or	  
SF3B1	   for	   the	   different	   timepoints.	   D.	   Correlation	   matrix	   and	   robust	   correlation	  
values	  between	  IK	  or	  SMU1	  knockdowns	  at	  different	  time	  points.	  	  	  	  	  
	  
	   	   	  
	  
Figure	  S3.	  Regulation	  of	  AS	  events	  involved	  in	  cell	  proliferation	  or	  apoptosis	  based	  
on	  functional	  annotations.	  A.	  Heatmap	  representation	  of	  the	  results	  obtained	  in	  the	  
screen	   experiment	   based	   on	   functional	   annotations	   of	   the	   AS	   events.	   Blue	   or	   red	  
colors	  indicate	  splicing	  changes	  towards	  more	  cell	  proliferation/less	  apoptosis	  or	  less	  
cell	   proliferation/more	   apoptosis	   for	   a	   given	   knockdown	   condition,	   respectively.	  
Data	   are	   clustered	   on	   both	   dimensions	   (similarity	   measure	   based	   on	   Pearson	  
correlation,	   ward	   linkage).	   B	   and	   C.	   Extent	   and	   direction	   of	   AS	   changes	   upon	  
knockdown	   of	   subsets	   of	   splicing	   factors.	   Box-­‐plots	   represent	   the	   skewness	   and	  
spread	  of	  the	  mean	  z-­‐scores	  for	  AS	  splicing	  changes	  observed	  across	  the	  AS	  events	  
analyzed	   for	   core	   and	   non-­‐core	   splicing	   factors,	   other	   RNA	   processing	   factors	   and	  
chromatin	   factors	   (A)	   or	   for	   factors	   that	   are	   either	   persistent	   or	   transient	  
components	  of	  the	  spliceosome	  at	  different	  stages	  of	  assembly	  (B).	  EJC	  corresponds	  
to	  components	  of	  the	  Exon	  Junction	  Complex.	  
	  
Figure	  S4.	   Sub-­‐network	   topologies.	  A.	  Detailed	  functional	   interactions	  of	  U2snRNP	  
proteins.	   B.	   Detailed	   functional	   interactions	   among	   U4/5/6	   tri-­‐snRNP	   proteins.	   C.	  
Functional	   interactions	   between	   PRP19	   and	   Nineteen	   Complex	   components.	   D.	  
Functional	   interactions	   between	   Sm	   core	   proteins.	   E.	   Top	   5	   functional	   network	  
connections	   between	   persistent	   and	   different	   transient	   components	   of	   the	  
spliceosome	  at	  different	  stages	  of	  assembly	  based	  on	  robust	  correlation	  values.	  
	  
Figure	   S5.	   Genome-­‐wide	   regulation	   of	   AS	   by	   IK	   and	   SMU1	   and	   links	   with	   cell	  
proliferation	   and	   apoptosis.	  A.	  Depletion	  of	   IK	  and	  SMU1	  protein	   levels	  by	   siRNA-­‐
mediated	  knockdown	  at	  48	  or	  72	  hours.	  The	  proteins	  were	  detected	  by	  western	  blot	  
	   	   	  
	  
analysis	   under	   the	   indicated	   conditions.	   B.	   Overlap	   between	   gene	   expression	  
changes	  upon	  knockdown	  of	  IK	  or	  SMU1	  by	  RNAi.	  Upper	  panel:	  up-­‐regulated	  genes.	  
Lower	  panel:	  down-­‐regulated	  genes.	   	  C.	  Overlap	  in	  AS	  changes	  upon	  knockdown	  of	  
IK	   or	   SMU1	  by	  RNAi.	  Upper	   panel:	   changes	   leading	   to	   up-­‐regulation	  of	   alternative	  
exons.	   Lower	   panel:	   changes	   leading	   to	   down-­‐regulation	   of	   alternative	   exons.	   	   D.	  
Gene	  ontology	  analysis	  for	  genes	  or	  exons	  up-­‐	  or	  down-­‐regulated	  upon	  IK	  or	  SMU1	  
knockdown	   using	   Ingenuity	   pathway	   tools.	   	   E.	   Induction	   of	   α-­‐PARP-­‐cleavage,	   a	  
feature	   of	   apoptotic	   cells,	   upon	   siRNA-­‐mediated	   knockdown	   of	   IK,	   SMU1	   or	   both.	  
Western	   blots	   (two	   upper	   panels)	   were	   carried	   out	   using	   protein	   extracts	   of	   cells	  
transfected	  with	  specific	  siRNAs	  or	  controls.	  β-­‐tubulin	  was	  used	  as	   loading	  control.	  
RT-­‐PCR	   assays	   (lower	   two	  panels)	  were	  used	   to	   detect	   changes	   in	  AS	   of	   Fas/CD95	  
and	   MCL1	   endogenous	   transcripts.	   F.	   IK	   and/or	   SMU1	   knock	   reduce	   cell	  
proliferation.	   HeLa	   cells	   were	   transfected	   in	   sixtuplicate	   with	   siRNAs	   against	   IK,	  
SMU1	   or	   the	   combination	   of	   both	   and	   cell	   numbers	   were	   determined	   using	  	  
resazurin	   (which	  measures	   aerobic	   respiration)	   at	   different	   time	  points.	   Error	   bars	  
represent	  standard	  deviations	  for	  a	  given	  siRNA	  condition.	  G.	  IK	  and/or	  SMU1	  knock	  
promote	  apoptosis.	  HeLa	  cells	  were	  transfected	   in	  sextuplicate	  with	  siRNAs	  against	  
IK,	  SUM1	  or	  both	  and	  IK	  and	  SMU1	  were	  depleted	  by	  siRNA	  transfection,	  	  isolated	  at	  
different	   time	   points	   and	   different	   cell	   populations	   analyzed	   by	   flow	   cytometry	  
sorting	   after	   staining	   with	   annexin	   V	   and	   propidium	   iodide.	   	   The	   fraction	   of	   cells	  
under	  different	  knockdown	  conditions	  is	  shown.	  
	  
Figure	   S6.	   Analysis	   of	   variable	   functional	   interactions	   in	   the	   AS	   network.	   A.	  
Principal	  components	  analysis	  of	   functional	   interactions	  extracted	  by	  subsets	  of	  AS	  
	   	   	  
	  
events	   (see	   also	  Methods).	   Colors	   indicate	   the	   positions	   of	   the	   interactions	   in	   the	  
Principal	  Component	  Analysis,	  which	  captures	  the	  different	  relative	  contributions	  of	  
the	   35	   AS	   events	   in	   defining	   these	   connections.	   	   The	   top	   ten	   discriminatory	   AS	  
events	  based	  on	  their	   loadings	  on	  the	  first	  two	  principal	  components	  are	  shown	  as	  
grey	   arrows.	   The	   numbers	   identify	   the	   functional	   connections	   between	   splicing	  
factors	  and	  are	  detailed	  in	  the	  table	  at	  the	  bottom.	   	  B	  and	  C.	  Representation	  of	   	  z-­‐	  
score	   values	   of	   AS	   changes	   upon	   knockdown	   of	   U2AF1	   or	   HNRPC	   for	   AS	   events	  
harboring	  (B)	  or	  not	  (C)	  composite	  HNRPC	  binding/3’	  splice	  site-­‐like	  elements	  within	  
400	   nucleotides	   of	   the	   alternative	   cassette	   exon	   boundaries.	   Robust	   correlation	  
values	  are	  indicated	  within	  each	  panel.	  D	  and	  E.	  Representation	  of	  z-­‐score	  values	  of	  
AS	   changes	  upon	   knockdown	  of	  U2AF1	  or	  HNRNPC	   for	  AS	  events	  harboring	   (D)	  or	  
not	  (E)	  Alu	  elements	  within	  0.5	  kbp	  of	  the	  alternative	  cassette	  exon	  boundaries.	  
	  
Table	  S1.	  Information	  on	  AS	  events	  analyzed	  in	  this	  study.	  The	  information	  includes	  
gene	  symbol,	  id,	  exon	  sequence	  and	  genomic	  coordinates	  for	  the	  AS	  exons	  analyzed.	  
	  
Table	   S2.	   Information	   about	   the	   custom	   siRNA	   library	   utilized	   to	   knockdown	  
splicing	  and	  chromatin	   factors.	   Information	  includes	  siRNA	  pools	  catalog	  numbers,	  
gene	   symbol,	   id	   and	   accession	   numbers	   for	   the	   targeted	   genes.	   It	   also	   includes	  
information	   about	   the	   categories	   in	   which	   their	   protein	   products	   were	   classified	  
according	   to	   two	   publications	   (Wahl	   et	   al.,	   2009	   and	   Zhou	   et	   al.,	   2002),	   the	  
classifications	   used	   in	   our	   network	   analysis	   and	   also	   information	   about	   their	  
functions	  and	  known	  interactions.	  	  
	  
	   	   	  
	  
Table	   S3.	   Raw	   data	   of	   AS	   changes	   upon	   knockdown	   of	   splicing	   and	   chromatin	  
factors.	  Each	  sheet	  contains	   the	  data	  corresponding	  to	  one	  AS	  event.	  Data	   include	  
information	   about	   the	   genes	   knocked	   down,	   the	   corresponding	   siRNA	   pools,	  
quantification	   of	   alternative	   isoforms	   by	   RT-­‐PCR	   and	   high-­‐throughput	   capillary	  
electrophoresis	   and	  percentage	  of	   exon	   inclusion	   (PSI	   index)	   for	   each	  of	   the	   three	  
biological	  replicas	  as	  well	  as	  the	  median,	  standard	  deviation,	  p	  value	  and	  z-­‐scores	  for	  
the	  three	  values.	  	  
	  
Table	  S4	  .	  Compendium	  of	  raw	  data	  of	  AS	  changes	  upon	  knockdown	  of	  splicing	  and	  
chromatin	  factors	  (classified	  according	  to	  factor	  classes),	  upon	  knockdown	  of	  P14,	  
SF3B1	  and	  SNRPG	  with	   two	   independent	   siRNA	   libraries,	  upon	  knockdown	  of	   IK-­‐
SMU1	  core	  splicing	  factors	  at	  different	  time	  points	  or	   in	  different	  cell	   lines,	  upon	  
treatment	   with	   drugs	   targeting	   the	   spliceosome	   and	   upon	   pharmacological	  
treatments	   involved	   in	   iron	   homeostasis	   modulation	   (data	   from	   Tejedor	   et	   al.,	  
accompanying	  manuscript).	  
	  
	  
Table	  S5.	  Robust	  correlation	  values	  and	  glasso	  inverse	  covariance	  estimates	  for	  the	  
complete	  network	  edge-­‐list.	  	  
	  
Table	  S6.	  Oligonucleotide	   sequences	  and	   information	  about	  amplicons	  utilized	   in	  
semi	  quantitative	  RT-­‐PCR	  (sheet	  1)	  assays	  or	  real	  time	  PCR	  	  analysis	  (sheet	  2)	  used	  
in	  this	  study	  	  
	   	   	  
	  
Detailed	  information	  and	  references	  for	  the	  Splicing	  events	  analyzed	  can	  be	  found	  
at	  the	  following	  link:	  
https://s3.amazonaws.com/SplicingNet/ASEs.zip	  
The	   files	   include	   a	   schematic	   representation	   for	   every	   AS	   event;	   information	  
regarding	   the	   functional	   role	   of	   the	   gene,	   as	   retrieved	   from	   uniprot	   /	   genecards	  
database;	  the	  protein	  domain	  affected	  by	  the	  AS	  event;	  the	  functional	  effect	  of	  each	  
of	  the	  isoforms	  towards	  cell	  proliferation	  or	  apoptosis;	  and	  102	  references	  consulted	  
for	  the	  selection.	  
	  
	  
	  
Supplementary	  Methods	  
Cell	  lines	  
HeLa	  CCL-­‐2	  cells	  and	  HEK293	  cells	  were	  purchased	  from	  the	  American	  Type	  Culture	  
Collection	   (ATCC).	   Cells	   were	   cultured	   in	   Glutamax	   Dulbecco’s	   modified	   Eagle’s	  
medium	   (Gibco,	   Life	   Technologies)	   supplemented	   with	   10%	   fetal	   bovine	   serum	  
(Gibco,	   Life	   Technologies)	   and	   penicillin/streptomycin	   antibiotics	   (penicillin	   500	  
u/ml;	  streptomycin	  0.5	  mg/ml,	  Life	  Technologies).	  Cell	  culture	  was	  performed	  in	  cell	  
culture	  dishes	  in	  a	  humidified	  incubator	  at	  37oC	  under	  5%	  CO2.	  
	  
Drug	  Treatments	  
Pharmacological	   treatments	   with	   splicing	   arresting	   drugs	   were	   performed	   as	  
described	   in	   Corrionero	   et	   al.	   (2011).	   HeLa	   cells	   were	   treated	   for	   3	   hours	   with	  
Spliceostatin	  A	  260	  nM	  or	  8	  hours	  with	  Meayamycin	  20	  nM	  or	  TG003	  10	  µM.	  RNA	  
	   	   	  
	  
was	  isolated	  using	  the	  Maxwell	  16	  LEV	  simplyRNA	  kit	  (Promega)	  and	  RT	  PCRs	  for	  the	  
35	  splicing	  events	  were	  performed	  as	  described	  above.	  	  
	  
Cell	  proliferation	  assays	  
HeLa	  cells	  were	   forward-­‐transfected	  with	  siRNAs	  targeting	   IK,	  SMU1	  or	  both	  genes	  
by	   plating	   2500	   cells	   over	   a	   mixture	   containing	   siRNA-­‐RNAiMAX	   lipofectamine	  
complexes,	   as	   previously	   described.	   Indirect	   estimations	   of	   cell	   proliferation	   were	  
obtained	   24,	   48	   and	   72	   hours	   post	   transfection	   by	   treating	   the	   cells	   for	   4h	   with	  
resazurin	   (5	   µM)	   prior	   to	   the	   fluorescence	  measurements	   (544	   nm	   excitation	   and	  
590	  nm	  emission	  wavelengths).	  Plate	  values	  were	  obtained	  with	  an	  Infinite	  200	  PRO	  
series	  multiplate	  reader	  (TECAN).	  
	  
Cell	  apoptosis	  assays	  
Hela	  cells	  were	  transfected	  with	  siRNAs	  against	  IK,	  SMU1	  or	  both	  genes,	  as	  described	  
above.	  Cells	  were	  trypsinized	  and	  collected	   for	  analysis	  72	  hours	  post	   transfection.	  
Pellets	   were	   washed	   once	   with	   complete	   DMEM	   medium	   (10%	   serum	   plus	  
antibiotics),	   and	   three	   times	   with	   PBS	   1X.	   Cells	   were	   then	   resuspended	   in	   200	   µl	  
Binding	   buffer	   provided	   by	   the	   Annexin	   V-­‐FITC	   Apoptosis	   Detection	   Kit	  
(eBiosciences),	   resulting	   in	  a	   final	  density	  of	  4x105	   cells/ml.	  5	  µl	  of	  Annexin	  V-­‐FITC	  
was	  added	   to	  each	  sample	   followed	  by	  10	  min	   incubation	  at	   room	  temperature	   in	  
dark	  conditions.	  Cells	  were	  washed	  once	  with	  500	  µl	  binding	  buffer	  and	   incubated	  
with	  10	  µl	  propidium	  iodide	  (20	  µg/ml)	  for	  5	  minutes.	  FACS	  analysis	  was	  performed	  
using	  a	  FACSCalibur	  flow	  cytometry	  system	  (BD	  Biosciences).	  	  	  
	  
	   	   	  
	  
Western	  blots	  
Protein	   extraction	   was	   performed	   in	   RIPA	   buffer	   and	   protein	   abundance	   was	  
estimated	  by	  Bradford	  assay.	  Thirty	  to	  Forty	  µg	  of	  total	  protein	  were	  fractionated	  by	  
electrophoresis	   in	   10%	   Bis-­‐Tris	   polyacrilamide	   gels	   and	   transferred	   to	   PVDF	  
membranes.	   Primary	   antibodies	   used	   in	   this	   study	   are	   listed	   below:	   IK	   (rabbit	  
polyclonal,	  Origene	   TA308401),	   SMU1	   (mouse	  monoclonal,	   Santa	   Cruz	   Biotech,	   sc-­‐
100896	   JS-­‐12),	   PARP	   (rabbit	   polyclonal,	   cell	   signaling,	   9542S),	   β-­‐Tubulin	   (mouse	  
monoclonal,	   Sigma-­‐Aldrich,	   T4026),	   SF3B1	   (rabbit	   polyclonal,	   Abcam,	   ab39578),	  
SNRPG	   (rabbit	   polyclonal,	   Abcam,	   ab111194),	   SLU7	   (rabbit	   polyclonal,	   gift	   from	  
Robin	  Reed),	  U2AF65	   (mouse	  monoclonal,	  MC3	   clone),	   SRSF1	   (mouse	  monoclonal,	  
gift	  from	  Adrian	  Krainer),	  BRR2	  (rabbit	  polyclonal,	  Sigma,	  -­‐HPA029321)	  
	  
Real	  time	  qPCR	  
First	   strand	   cDNA	   synthesis	   was	   set	   up	   with	   500	   ng	   of	   RNA,	   50	   pmol	   of	   oligo-­‐dT	  
(Sigma-­‐Aldrich),	   75	   ng	   of	   random	   primers	   (Life	   Technologies),	   and	   superscript	   III	  
reverse	   transcriptase	   (Life	   Technologies)	   in	   20	   µl	   final	   volume,	   following	   the	  
manufacturer’s	   instructions.	  Quantitative	  PCR	  amplification	  was	  carried	  out	  using	  1	  
µl	  of	  1:2	  to	  1:4	  diluted	  cDNA	  with	  5	  µl	  of	  2X	  SYBR	  Green	  Master	  Mix	  (Roche)	  and	  4	  
pmol	  of	  specific	  primer	  pairs	   in	  a	  final	  volume	  of	  10	  µl	   in	  384	  well-­‐white	  microtiter	  
plates,	  Roche).	  qPCR	  mixes	  were	  analyzed	  in	  triplicates	  in	  a	  Light	  Cycler	  480	  system	  
(Roche)	   and	   fold	   change	   ratios	   were	   calculated	   according	   to	   the	   Pfaffl	   method	  
(Pfaffl,	  2001).	  Primers	  sequences	  used	  in	  this	  study	  are	  indicated	  in	  Table	  S6.	  	  
	  
Affymetrix	  arrays	  
	   	   	  
	  
HeLa	   cells	   were	   transfected	   with	   siRNAs	   against	   IK,	   SMU1	   or	   RBM6	   in	   biological	  
triplicate	  as	  described	  above	  or	  –for	  RBM6-­‐	  as	  described	  in	  Bechara	  et	  al.,	  2013.	  RNA	  
was	   isolated	   using	   the	   RNeasy	   minikit	   (Quiagen).	   RNA	   quality	   was	   estimated	   by	  
Agilent	   Bioanalyzer	   nano	   assay	   and	   samples	   were	   hybridized	   to	   GeneChip	   Human	  
Exon	   1.0	   ST	   Array	   (Affymetrix)	   by	   Genosplice	   Technology.	   Array	   analysis	   was	  
performed	   by	   Genosplice	   Technology	   and	   the	   data	   (gene	   expression,	   alternative	  
splicing	   changes	   and	   gene	   ontologies	   upon	   IK,	   SMU1	   knockdown	   conditions)	   is	  
available	   at:	   https://s3.amazonaws.com/SplicingNet/HJAY_arrays.zip	   and	   at	   GEO	  
database	  with	  the	  accession	  number	  GSE56605	  .	  
	  
Glasso-­‐based	  Network	  Reconstruction	  from	  Robust	  Correlation	  Estimates	  
Here	   we	   describe	   the	   process	   of	   deriving	   an	   undirected	   network	   that	   models	  
functional	   interconnections	   of	   splicing	   perturbations	   based	   on	   the	   effects	   of	   gene	  
KDs/cell-­‐perturbing	  stimuli	  on	  ASEs.	  The	  main	  steps	  are:	  
1. Data	  preprocessing	  and	  reduction.	  This	  involves:	  
1.1. Removal	  of	  sparse	  variables	  and	  imputation	  of	  missing	  values.	  
1.2. Removal	  of	  uninformative	  events.	  
1.3. Data	  scaling	  (standardization).	  
2. Robust	  sample	  covariance	  estimation.	  	  
3. Network	   reconstruction	   based	   on	   the	   graphical	   lasso	   (glasso)	   model	   selection	  
algorithm.	  	  
In	   the	   next	   sections	  we	   describe	   the	   basis	   and	   algorithmic	   details	   for	   each	   of	   the	  
above	  steps.	  	  
	  
	   	   	  
	  
	  
1. 	  Data	  preprocessing	  and	  reduction.	  
	  
1.1	  Removal	  of	  sparse	  variables	  and	  imputation	  of	  missing	  values	  
Estimation	  of	  the	  sample	  covariance	  matrix	  requires	  complete	  data.	  However	  the	  p	  x	  
n	  matrix	  that	  contains	  the	  measurements	  of	  the	  p	  variables	  (genes)	   in	  n	  conditions	  
(ASEs)	  includes	  missing	  (NA)	  values.	  In	  order	  to	  overcome	  this	  problem,	  first	  sparse	  
variables	   (#NA	   values	   >	   n/2)	   are	   removed.	   The	   remaining	   missing	   values	   are	  
subsequently	  filled-­‐in	  by	  applying	  k-­‐nearest-­‐neighbor	  based	  imputation	  (Hastie	  et	  al.,	  
1999,	   R	   function	   impute	   available	   as	   part	   of	   the	   bioconductor	   project	   at	  
http://www.bioconductor.org/).	  For	  the	  purposes	  of	  this	  work	  we	  set	  k=ceiling(0.25	  
sqrt(p)).	  
	  
1.2	  Removal	  of	  uninformative	  ASEs.	  
ASEs	  not	  affected	  to	  a	  significant	  degree	  (median	  absolute	  (ΔPSI)<1)	  by	  the	  KDs	  offer	  
little	   information	  on	  the	  genes’	  covariance	  and	  can	  potentially	   introduce	  noise	  and	  
are	  thus	  discarded	  from	  subsequent	  analyses.	  	  
	  
	  
1.3	  Data	  Scaling.	  
Prior	  to	  sample	  covariance	  estimation	  the	  data	  matrix	  is	  standardized	  along	  the	  gene	  
dimensions.	  Standardization	  of	  the	  events	  ensures	  that	  only	  the	  shape	  and	  not	  the	  
magnitude	  of	  the	  fluctuations	  is	  taken	  into	  account	  for	  covariance	  estimation	  and	  it	  
is	  equivalent	  to	  using	  correlation	  in	  lieu	  of	  covariance	  in	  all	  downstream	  analyses.	  	  
	   	   	  
	  
	  
2.	  Robust	  sample	  correlation	  estimation.	  
When	   outliers	   are	   present	   they	   dominate	   the	   correlation	   estimates.	   In	   order	   to	  
overcome	   the	   sensitivity	   of	   sample	   correlation	   to	   outliers	   we	   derive	   robust	  
correlation	  estimates	  based	  on	  a	  weighting	  algorithm	  that	  attempts	  to	  discriminate	  
between	  technical	  outliers	  and	  reliable	  influential	  measurements.	  
In	  particular,	   starting	  with	   an	  M	  =	  p	  x	  n	   dataset	  of	  p	   standardized	   variables	   and	  n	  
samples	   we	   wish	   to	   derive	   a	   robust	   correlation	   p	   x	   p	   matrix.	   We	   calculate	   the	  
influence	  of	  a	  sample	  u	   in	   the	  estimation	  of	   the	  correlation	  of	   two	  variables	  Xa,	  Xb	  
using	  the	  deleted	  residual	  distance:	  
	  
Where	  p(Xa,	  Xb)	  and	  	  p-­‐u(Xa,Xb)	  are	  the	  Pearson’s	  correlation	  estimates	  before	  or	  after	  
removing	  the	  observations	  Mau,	  Mbu	  coming	  from	  sample	  u.	  
A	  measure	  of	  the	  reliability	  𝑅!,!! 	  of	   these	  measurements	   for	  the	  estimation	  of	  p(Xa,	  
Xb)	  given	  all	   the	  observed	  data	   is	  then	  based	  on	  their	  cumulative	   influence	  on	  high	  
correlates	  of	  Xa,	  and	  Xb:	  
	  
	  
where	  𝕀 𝑎, 𝑖 	  is	  the	  indicator	  function:	  	  
	  
T	  	  being	  a	  minimum	  correlation	  threshold	  for	  considering	  a	  pair	  of	  variables.	  
!! !! ,!! = ! !! ,!! − !!! !! ,!! !
!! ,!! = 1/ ! !! !! ,!! !(!, !)+ !! !! ,!! !(!, !)!!!!!!!! !(!, !)+ !(!, !)!!!!!!!! !
! !, ! ≔ 1!if#! ≠ !!!"#!|! !! ,!! | > !!0!otherwise !
	   	   	  
	  
The	   final	   robust	   correlation	   estimates	   are	   finally	   calculated	   as	   the	   weighted	  
Pearson’s	   correlation	   p(Xa,	   Xb;w)	   where	   w	   is	   a	   vector	   of	   weights	   of	   length	   n	  
containing	  the	  values	  𝑅!,!!   for	  every	  observation	  u.	  	  
Intuitively,	   if	   an	   observation	   Mau	   distorts	   correlation	   estimates	   among	   all	   highly	  
correlated	  partners	  of	  Xa	   it	   is	   considered	  an	  outlier	   and	   is	  down-­‐weighted.	  On	   the	  
other	  hand	  if	  including	  this	  observation	  yields	  similar	  correlation	  estimates	  for	  most	  
of	  these	  pairs	  it	  is	  considered	  reliable	  even	  if	  its	  influence	  on	  the	  individual	  estimate	  
of	  p(Xa,	   Xb)	   is	   high.	   The	   advantage	   of	   this	   procedure	   is	   that	   it	   derives	  weights	   for	  
individual	   measurements	   (as	   opposed	   to	   a	   single	   weight	   for	   every	   sample)	   while	  
taking	  into	  account	  the	  complete	  dataset.	  
The	   algorithm	   can	   be	   used	   iteratively,	   however	   in	   our	   experience	   the	   estimates	  
converge	  within	  1	  to	  2	  iterations.	  	  R	  code	  for	  implementing	  this	  algorithm	  is	  available	  
upon	  request.	  Examples	  of	  robust	  correlation	  estimates	  and	  regression	  based	  on	  this	  
metric	  and	  taken	  from	  our	  dataset	  are	  shown	  below:	  
	  
	  
	  
3.	  	  Graphical	  model	  selection	  for	  Network	  Reconstruction	  using	  Graphical	  Lasso	  
−4 −3 −2 −1 0 1
−5
−4
−3
−2
−1
0
1
Z−score  RBM17
Z−
sc
or
e 
 C
RN
KL
1
FasOlr1
Pax6Chek2
FN1EDB
FN1EDA NUMB
BCL2L1
Rac1
MSTR1
MADD
CASP2
APAF1
MINK1
MAP3K7
MAP4K3
NOTCH3 MAP4K2PKM2
MCL1
CFLAR
CASP9
DIABLO
BMF
CCNE1
H2AFY
STAT3
GADD45ABIM_L_EL
BIM_ELBIRC5_2B
BIRC5_D3
SMN1
SMN2
PHF19
ClassCor = 0.66
RobCor = 0.03
−4 −3 −2 −1 0 1 2
−3
−2
−1
0
1
2
3
4
Z−score  CDC5L
Z−
sc
or
e 
 S
KI
IP
FasOlr1
Pax6
Chek2
FN1EDB
FN1EDA
NUMB
BCL2L1
Rac1
MSTR1
MADD
CASP2
APAF1
MINK1
MAP3K7
MAP4K3
NOTCH3
MAP4K2
PKM2
MCL1
CFLAR
CASP9
DIABLO
BMF
CCNE1
H2AFY
STAT3
GADD45A
BIM_L_ELBIM_EL
BIRC5_2B
BIRC5_D3
SMN1
SMN2PHF19
ClassCor = 0.26
RobCor = 0.5
	   	   	  
	  
	  
Undirected	   graphical	   models	   (UGMs)	   such	   as	   Markov	   random	   fields	   (MRFs)	  
represent	   real-­‐world	  networks	  and	  attempt	   to	  capture	   important	   structural	  and	  
functional	   aspects	   of	   the	   network	   in	   the	   graph	   structure.	   The	   graph	   structure	  
encodes	   conditional	   independence	   assumptions	   between	   variables	  
corresponding	  to	  nodes	  of	  the	  network.	  The	  problem	  of	  recovering	  the	  structure	  
of	  the	  graph	  is	  known	  as	  model	  selection	  or	  covariance	  estimation.	  	  
	   In	  particular,	  let	  G=(V,E)	  be	  an	  undirected	  graph	  on	  p=|V|	  nodes.	  Given	  n	  
independent,	   identically	   distributed	   (i.i.d)	   samples	   of	   X=(X1,…,Xp),	   we	   wish	   to	  
identify	   the	   underlying	   graph	   structure.	   We	   restrict	   the	   analysis	   to	   Gaussian	  
MRFs	   where	   the	   model	   assumes	   that	   the	   observations	   are	   generated	   from	   a	  
multivariate	  Gaussian	  distribution	  N(µ,Σ).	  Based	  on	   the	  observation	   that	   in	   the	  
Gaussian	   setting,	   zero	   components	   of	   the	   inverse	   covariance	   matrix	   Σ-­‐1	  
correspond	   to	   conditional	   independencies	   given	   the	   other	   variables,	   different	  
approaches	  have	  been	  proposed	  in	  order	  to	  estimate	  Σ-­‐1.	  
Graphical	  lasso	  (gLasso)	  provides	  an	  attractive	  solution	  to	  the	  problem	  of	  
covariance	   estimation	   for	   undirected	   models,	   when	   graph	   sparsity	   is	   a	   goal	  
(Friedman	   et	   al.,	   2008).	   The	   gLasso	   algorithm	   has	   the	   advantage	   of	   being	  
consistent,	  i.e.	  in	  the	  presence	  of	  infinite	  samples	  its	  parameter	  estimates	  will	  be	  
arbitrarily	  close	  to	  the	  true	  estimates	  with	  probability	  1.	  
L1	  regularization	  (lasso)	  is	  a	  smooth	  form	  of	  subset	  selection	  for	  achieving	  
sparsity.	   In	   the	   case	   of	   gLasso	   the	  model	   is	   constructed	   by	   optimizing	   the	   log-­‐
likelihood	  function:	  
	   	   	  
	  
Where	  Θ	   is	   an	  estimate	   for	   the	   inverse	   covariance	  matrix	  Σ-­‐1,	  S	   is	   the	  empirical	  
covariance	  matrix	  of	  the	  data,	  ||Θ||1	  is	  the	  L1	  norm	  i.e	  the	  sum	  of	  the	  absolute	  
values	   of	   all	   elements	   in	  Θ	   -­‐1,	   and	   r	   is	   a	   regularization	   parameter	   (in	   this	   case	  
selected	  based	  on	  estimates	  of	   the	  FDR,	   see	  below).	   The	   solution	   to	   the	  glasso	  
optimization	  is	  convex	  and	  can	  be	  obtained	  using	  coordinate	  descent.	  
The	  glasso	  process	  for	  network	  reconstruction	  was	  implemented	  using	  the	  glasso	  
R	   package	   by	   Jerome	   Friedman,	   Trevor	   Hastie	   and	   Rob	   Tibshirani	  
(http://statweb.stanford.edu/~tibs/glasso/).	  
	  
4.	  Partition	  of	  Network	  into	  modules.	  
Network	  modules	   or	   communities	   can	   be	   defined	   loosely	   as	   sets	   of	   nodes	  with	   a	  
more	  dense	  connection	  pattern	  among	  their	  members	  than	  between	  their	  members	  
and	   the	   remainder	   of	   the.	  Module	   detection	   in	   real-­‐world	   graphs	   is	   a	   problem	   of	  
considerable	   practical	   interest	   as	   they	   often	   capture	   meaningful	   functional	  
groupings.	  
	   Typically	   community	   structure	   detection	   methods	   try	   to	   maximize	  
modularity,	  a	  measure	  of	  the	  overall	  quality	  of	  a	  certain	  network	  partition	  in	  terms	  
of	   the	   identified	  modules	   (Newman,	  2006).	   In	  particular,	   for	  a	  network	  partition	  p,	  
the	  network	  modularity	  M(p)	  is	  defined	  as:	  	  
	  
log detΘ− !" !Θ − ! Θ !!
! ! = !!! − !!2! !!!!! !
	   	   	  
	  
where	  m	   is	   the	   number	   of	  modules	   in	   p,	   	   lk	   is	   the	   number	   of	   connections	  within	  
module	   k,	   L	   is	   the	   total	   number	   of	   network	   connections	   and	  dk	   is	   the	   sum	  of	   the	  
degrees	  of	  the	  nodes	  in	  module	  k.	  
Here,	  we	  identify	  modules	  of	  genes	  that	  exhibit	  similar	  perturbation	  profiles	  among	  
the	   assayed	   events	   by	   maximizing	   the	   network’s	   modularity	   using	   the	   greedy	  
community	   detection	   algorithm	   (Clauset	   et	   al.,	   2004)	   implemented	   in	   the	  
fastgreedy.community	   function	   of	   the	   igraph	   package	   (Csardi	   and	   Nepusz,	   2006,	  
http://igraph.sourceforge.net/doc/R/fastgreedy.community.html).	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